Health Care News and Research

RSS

Longer reads: HIV secrets, millennials' mental health and sleeping pills without side effects

Every week reporter Ankita Rao selects interesting reading from around the Web.

6 Dec 2013

Pace of health insurance applications picks up

News outlets in Wisconsin and Minnesota report increases in applications for coverage through new online marketplaces. But baby boomers, as opposed to so-called "young invincibles," dominate sign-ups in Colorado, while in California, Democratic lawmakers worry a lookalike website set up by Republican lawmakers will lead some applicants astray.

6 Dec 2013

Cancer triggers scleroderma, shows evidence

Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and hardening of the skin and widespread organ damage.

6 Dec 2013

Medicaid signups may be affected by website glitches

The federal government has been unable to transfer full Medicaid applications to the 36 states participating in healthcare.gov, potentially leaving some who sign up for Medicaid without coverage.

5 Dec 2013

The White House's latest health law campaign message

A key to this "messaging" effort is highlighting the popular parts of the overhaul and connecting it to better economic conditions.

5 Dec 2013

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

Presence Health, the largest Catholic health system based in Illinois, significantly increased screening rates for colorectal cancer by utilizing automated, interactive voice response calls, according to research being presented on Dec. 10 at the Institute for Healthcare Improvement's 25th Annual National Forum on Quality Improvement in Health Care.

5 Dec 2013

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

5 Dec 2013

Widely varying drug costs in new health plans

The Wall Street Journal explores out-of-pocket drug costs in plans offered on the health law's exchanges. Other stories probe so called "aggregation rules" that could affect some small businesses and the law's potential impact on safety-net hospitals and clinics.

5 Dec 2013

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.

5 Dec 2013

First Edition: December 5, 2013

Today's headlines include reports about how President Barack Obama is trying to connect with young adults and urge them to sign up for health coverage.

5 Dec 2013

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Cabergoline Tablets USP, 0.5 mg. Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

5 Dec 2013

Medicines for rare diseases may be effectively valued using multi-criteria decision analysis

A study just published by the Office of Health Economics and its collaborators demonstrates how medicines for rare disease may be effectively valued using an innovative approach -- multi-criteria decision analysis -- that can include all relevant stakeholders, including patients' groups.

5 Dec 2013

Elsevier strengthens long-standing relationship with China Science Publishing & Media

Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, and part of the Reed Elsevier group, announced today that it is strengthening and refocusing the scope of its long-standing relationship with China Science Publishing & Media Ltd. (CSPM) to create an international publishing platform for English-language STM journals that brings the expanding wealth of research originating from China to the world.

5 Dec 2013

WC claims result in no payment, but do lead to increased costs for employee group insurance plans

Many workers' compensation claims result in no payment from the WC system, but do lead to increased costs for employee group insurance plans, reports a study in the December Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

5 Dec 2013

Palomar Health becomes the newest member of Mayo Clinic Care Network

Mayo Clinic today announced Palomar Health, the largest public health care district in California, as the newest member of the Mayo Clinic Care Network. This agreement formalizes a unique relationship between the two institutions that will allow physicians and specialists to collaborate and provide Palomar Health patients with access to Mayo Clinic's experts and medical resources.

5 Dec 2013

St. Jude Medical evaluates effectiveness of PNfS and SCS for chronic low back and leg pain

St. Jude Medical, Inc., a global medical device company, has launched a clinical study to evaluate the combination of peripheral nerve field stimulation, and spinal cord stimulation, to determine whether the two therapies together offer more effective management of chronic low back and leg pain than SCS alone. The first patient in the SENSE Subcutaneous and Epidural Neuromodulation System Evaluation study was enrolled by Dr. Thomas Yearwood, an interventional pain physician at Comprehensive Pain & Rehabilitation in Pascagoula, Miss.

5 Dec 2013

State highlights: Caremark to pay MassHealth $2.6M after not reimbursing claims; Ore. bill would force lawmakers on to state insurance exchange

A selection of health policy stories from Massachusetts, Oregon, Kansas and North Carolina.

5 Dec 2013

Viewpoints: Why can't health website be like Amazon?; debunking GOP's resistance to Medicaid

For an "Amazon-like" experience, it isn't enough to have a website that functions on the front end, the back end and in between. ... You also need an Amazon-like culture, which is the product of other Amazon-like realities.

5 Dec 2013

Researchers present new method of wirelessly recharging medical device batteries with ultrasound

Human beings don't come with power sockets, but a growing numbers of us have medical implants that run off electricity. To keep our bionic body parts from powering down, a group of Arizona researchers is developing a safe, noninvasive, and efficient means of wireless power transmission through body tissue.

5 Dec 2013

Inspector general report: The IRS is ready to calculate subsidies but needs to strengthen ability to detect fraud

The report concluded that subsidies could be vulnerable to fraud -- marking yet another potential trouble spot for the health law's implementation.

5 Dec 2013

Health Care News and Research

Longer reads: HIV secrets, millennials' mental health and sleeping pills without side effects

Pace of health insurance applications picks up

Cancer triggers scleroderma, shows evidence

Medicaid signups may be affected by website glitches

The White House's latest health law campaign message

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

Widely varying drug costs in new health plans

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

First Edition: December 5, 2013

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

Medicines for rare diseases may be effectively valued using multi-criteria decision analysis

Elsevier strengthens long-standing relationship with China Science Publishing & Media

WC claims result in no payment, but do lead to increased costs for employee group insurance plans

Palomar Health becomes the newest member of Mayo Clinic Care Network

St. Jude Medical evaluates effectiveness of PNfS and SCS for chronic low back and leg pain

State highlights: Caremark to pay MassHealth $2.6M after not reimbursing claims; Ore. bill would force lawmakers on to state insurance exchange

Viewpoints: Why can't health website be like Amazon?; debunking GOP's resistance to Medicaid

Researchers present new method of wirelessly recharging medical device batteries with ultrasound

Inspector general report: The IRS is ready to calculate subsidies but needs to strengthen ability to detect fraud

Event guide: 3rd Measuring Patient Engagement Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News